Rheumatology

An early study positions a VAP-1-targeting PET tracer as an inflammation-specific biomarker for tracking activity in giant cell arteritis.

Elevated S1P levels in psoriatic arthritis were associated with disease progression, enthesitis, and structural damage.

Site-specific inflammation may be predetermined during fetal tissue development, according to a new study from the University of Oxford.

Women with systemic sclerosis face increased risks at pregnancy and a greater likelihood of reproductive hormone imbalances and sexual dysfunction, new research has found.

Classification criteria and recommendations for the diagnosis and clinical management of spondyloarthritis have been updated and were presented at EULAR 2026.

Researchers have highlighted, at EULAR 2026, different pathways through which the rheumatology patient’s experience can be enhanced.

Urate-lowering therapy in a treat-to-target strategy can foster higher remission rates in patients with gout, according to new data presented at EULAR 2026.

CAR-T cell therapies prove promising in treatment-refractory rheumatic and musculoskeletal diseases, according to new research presented at EULAR 2026.